Loss of γ-catenin expression in squamous differentiation in endometrial carcinomas

International Journal of Gynecological Pathology

Volumn 21, Issue 3, 2002, Pages 246-254

  Ashihara, Koji ^a   Saito, Tsuyoshi ^a   Mizumoto, Hisanobu ^a   Adachi, Katsuya ^a   Tanaka, Ryoichi ^a   Nishimura, Makoto ^a   Ito, Eiki ^a   Kudo, Ryuichi ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Catenin; Cell adhesion; Desmosome; Endometrioid carcinoma; Endometrium; Squamous differentiation

Indexed keywords

BETA CATENIN; DESMOPLAKIN; PLAKOGLOBIN;

ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; DESMOSOME; ENDOMETRIUM CARCINOMA; EXON; FEMALE; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL;

EID: 0036082154     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-200207000-00007     Document Type: Article

References (32)

1. Squamous differentiation in carcinoma of the endometrium: A critical appraisal of adenoacanthoma and adenosquamous carcinoma
2. Problems in the differential diagnosis of endometrial hyperplasia and carcinoma
3. Prognostic significance of squamous differentiation in stage I endometrial adenocarcinoma
4. The significance of squamous differentiation in endometrial carcinoma: Data from a Gynecologic Oncology Group study
5. The roles of catenins in the cadherin-mediated cell adhesion: Functional analysis of E-cadherin-alpha catenin fusion molecules
6. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein
7. The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin
8. Genomic rearrangements of the APC tumor-suppressor gene in familial adenomatous polyposis
9. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas
10. Beta-catenin mutations in human prostate cancer
11. Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma
12. Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations
13. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC
14. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene
15. Beta-catenin mutation in carcinoma of the uterine endometrium
16. Nuclear localization of beta-catenin in normal and carcinogenic endometrium
17. Plakoglobin and beta-catenin: Protein interactions, regulation and biological roles
18. Cytoskeleton-membrane interactions
19. Plakoglobin suppresses epithelial proliferation and hair growth in vivo
20. Expression of component desmosomal proteins in uterine endometrial carcinoma and their relation to cellular differentiation
21. Kinetics of desmosome assembly in Madin-Darby canine kidney epithelial cells: Temporal and spatial regulation of desmoplakin organization and stabilization upon cell-cell contact. II. Morphological analysis
22. Mutation of β-catenin gene in endometrial cancer but not in associated hyperplasia
23. Proliferation-associated regulation of telomerase activity in human endometrium and its potential implication in early cancer diagnosis
24. Coordinated expression of connexins 26 and 32 in human endometrial glandular epithelium during the reproductive cycle and the influence of hormone replacement therapy
25. Induction of cell transformation by mutated 16K vacuolar H+-atpase (ductin) is accompanied by down-regulation of gap junctional intercellular communication and translocation of connexin 43 in NIH3T3 cells
26. Regulation of LEF-1/TCF transcription factors by Wnt and other signals
27. Wnt signaling: A common theme in animal development
28. The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers
29. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer
30. Differential molecular interactions of beta-catenin and plakoglobin in adhesion, signaling and cancer
31. Suppression of tumorigenicity by plakoglobin: An augmenting effect of N-cadherin
32. beta-Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis